Sec Form 3 Filing - Machan Warren J @ AVANOS MEDICAL, INC. - 2024-10-28

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Machan Warren J 2. Issuer Name and Ticker or Trading Symbol AVANOS MEDICAL, INC. [ AVNS] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Interim CFO (Last) (First) (Middle) 5405 WINDWARD PKWY 3. Date of Earliest Transaction (MM/DD/YY) 10/28/2024 (Street) ALPHARETTA, GA30004 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 9,351 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Employee Stock Options (right to buy) $ 37.88 ( 1 ) 11/07/2024 Common Stock 1,600 D Employee Stock Options (right to buy) $ 45.47 ( 2 ) 03/05/2025 Common Stock 4,994 D Employee Stock Options (right to buy) $ 45.53 ( 3 ) 05/05/2025 Common Stock 5,609 D Employee Stock Options (right to buy) $ 29.48 ( 4 ) 04/01/2026 Common Stock 9,870 D Employee Stock Option (right to buy) $ 36.74 ( 5 ) 04/01/2026 Common Stock 8,979 D Employee Stock Option (right to buy) $ 52.1 ( 6 ) 04/01/2026 Common Stock 7,305 D Employee Stock Options (right to buy) $ 43.59 ( 7 ) 04/01/2026 Common Stock 16,379 D Employee Stock Option (right to buy) $ 28.87 ( 8 ) 04/01/2026 Common Stock 10,501 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Machan Warren J 5405 WINDWARD PKWY ALPHARETTA, GA30004 Interim CFO Signatures /s/ Mojirade James, as attorney-in-fact for Warren J. Machan pursuant to power of attorney filed herewith 11/06/2024 Signature of Reporting Person Date

Explanation of Responses:

( 1 )These options vested 30% on November 7, 2015, 30% on November 7, 2016, and 40% on November 7, 2017. ( 2 )These options vested 1/3 on each of March 5, 2018, March 5, 2019 and March 5, 2020. ( 3 )These options vested 30% on May 5, 2016, 30% on May 5, 2017, and 40% on May 5, 2018. ( 4 )These options vested 30% on May 5, 2017, 30% on May 5, 2018, and 40% on May 5, 2019. ( 5 )These ooptions vested 30% on May 3, 2018, 30% on May 3, 2019, and 40% on May 3, 2020. ( 6 )These options vested 30% on May 8, 2019, 30% on May 8, 2020, and 40% on May 8, 2021. ( 7 )These options vested 30% on May 8, 2020, 30% on May 8, 2021, and 40% on May 8, 2022. ( 8 )These options vested 30% on May 7, 2021, 30% on May 7, 2022 and 40% on May 7, 2023.

Remarks: The reporting person first became subject to Section 16 as an officer of the Issuer on October 31, 2014; ceased to be subject to Section 16 in 2018; again became subject to Section 16 in 2019; ceased to be subject to Section 16 in 2020; and retired effective April 1, 2021. The reporting person became a Section 16 officer again on October 28, 2024 and therefore is filing this Form 3.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.